All News

Ligand CEO Issues Letter to Captisol Customers
Ref: Business Wire
Tags: Press ReleaseLigand GileadCOVID-19 Marketing & SalesCaptisol Remdesivir
Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx
Ref: Business Wire
Tags: Press ReleaseAcelRx Pharmaceuticals Melinta Therapeutics Tetraphase Corporate Affairs Mergers & AcquisitionsXerava
Health Canada advises Canadians to help support the continued supply of medications
Ref: Health Canada
Tags: Press ReleaseCanada Health CanadaMarketing & Sales Regulatory Affairs
Covid-19 vaccine development moving positively, says Bharat Biotech CEO
Ref: Business Standard
Tags: NewsPointsBharatCOVID-19 Immunisation Clinical Research (R&D)
Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress
Ref: GlobeNewswire
Tags: Press ReleaseRelief Therapeutics NeuroRxCOVID-19 ARDS Clinical Research (R&D)RLF-100
Satsuma Completes Enrollment in Pivotal Phase 3 EMERGE trial of STS101 for Acute Treatment of Migraine
Ref: GlobeNewswire
Tags: Press ReleaseSatsuma PharmaceuticalsMigraine Clinical Research (R&D)STS101
argenx announces closing of global offering
Ref: GlobeNewswire
Tags: Press ReleasearGEN-X Corporate Affairs
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
Ref: PR Newswire
Tags: Press ReleaseArena Pharmaceuticals Corporate Affairs
Kaleido Biosciences Announces Proposed Public Offering of Common Stock
Ref: GlobeNewswire
Tags: Press ReleaseKaleido Biosciences Corporate Affairs
BioCryst Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
Ref: GlobeNewswire
Tags: Press ReleaseBioCryst Corporate Affairs